Inflammatory Myositis in a Child due to Anti-NXP2 Antibody, First Case Report from India

Ashok V Reddy Taallapalli1, Sumanth Shivaram1, Manisha Gupta1

  • 1Department of Neurology, National Institute of Mental Health and Neuro sciences (NIMHANS), Hosur Road, Bengaluru, Karnataka, India.

Neurology India
|July 22, 2022
PubMed

Insights

This study reports a rare case of anti-nuclear matrix protein 2 (NXP2) antibody-mediated inflammatory myositis in a child. Early diagnosis and immunomodulatory treatment led to significant improvement, highlighting the importance of NXP2 antibody testing.

Area of Science:

  • Pediatric Rheumatology
  • Neuromuscular Disorders
  • Autoimmune Diseases

Background:

  • Inflammatory myopathies are rare autoimmune disorders affecting muscles.
  • Anti-NXP2 antibody-associated myositis is a distinct subtype with specific clinical and imaging features.
  • Early diagnosis and treatment are crucial for managing pediatric inflammatory myopathies.

Observation:

  • A 10-year-old boy presented with proximal limb weakness, myalgias, contractures, and bulbar symptoms.
  • Elevated creatine phosphokinase (CPK) and positive anti-nuclear matrix protein 2 (NXP2) antibodies were detected.
  • Muscle MRI revealed active myositis with extensive signal changes in lower limb muscles.

Findings:

  • The patient showed significant clinical improvement following treatment with steroids, intravenous immunoglobulins (IVIg), and mycophenolate mofetil (MMF).
  • This case represents the first report of anti-NXP2 antibody-mediated inflammatory myositis from India.
  • The findings underscore the utility of NXP2 antibody testing in pediatric myositis.

Implications:

  • This case highlights the importance of considering anti-NXP2 antibody myositis in children with inflammatory muscle disease.
  • Prompt immunomodulatory therapy can lead to favorable outcomes in anti-NXP2 antibody-positive patients.
  • Further research is needed to understand the long-term prognosis and management strategies for this rare condition.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14